Brightsurf Science News & Current Events

November 03, 2012
Drug doesn't significantly lower risk of major heart problems in dialysis patients
In one of the largest and longest trials involving patients with kidney failure, a study led by an international team of researchers found that cinacalcet -- a drug commonly prescribed to patients with kidney failure and a disturbance of bone and mineral metabolism known as secondary hyperparathyroidism -- does not significantly reduce the risk of death or major cardiovascular events.

Penn Medicine expert wins AHA's Lifetime Achievement Award in Cardiac Resuscitation Science
Lance Becker, M.D., a professor of emergency medicine and director of the Center for Resuscitation Science at the Perelman School of Medicine at the University of Pennsylvania, will receive the American Heart Association's 2012 Award for Lifetime Achievement in Cardiac Resuscitation Science during the organization's annual Scientific Sessions.

People in 'crowdsourcing' challenge find defibrillators in Philadelphia
Participants in a

Mayo Clinic identifies promising treatment for inherited form of kidney disease
A drug therapy shows promise for treating an inherited form of kidney disease called autosomal dominant polycystic kidney disease, Mayo Clinic researchers say.

Advancing understanding of treatment through clinical trials
Three late-breaking studies presented during the American Society of Nephrology's Annual Kidney Week provide new information on drugs being tested in patients with diabetes or kidney disease.

Uranium a top subject at Geological Society of America Meeting
More than a dozen papers to be presented next week at the Geological Society of America Annual Meeting in North Carolina touch on aspects of uranium mining, environmental contamination, leakage, sorption, geochemistry, and mineral dating. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to